$EHC Balance Sheet | Understand Stock

$EHC

$124.10 +$0.01 (0.01%) Close

$EHC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable
Prepaid expenses and other current assets
Current assets of discontinued operations
Prepaid expenses
Other current assets
Total current assets

Property and equipment, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net
Other long-term assets
Noncurrent assets of discontinued operations
Total assets

Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt
Current operating lease liabilities
Accounts payable
Accrued medical insurance
Accrued payroll
Accrued interest payable
Accrued distributions
Accrued expenses and other current liabilities
Current liabilities of discontinued operations
Total current liabilities

Long-term debt, net of current portion
Long-term operating lease liabilities
Self-insured risks
Deferred income tax liabilities
Other long-term liabilities
Noncurrent liabilities of discontinued operations
Total liabilities
Redeemable noncontrolling interests
Shareholders’ equity:
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 116,036,500 in 2025; 116,036,500 in 2024
Capital in excess of par value
Accumulated income
Treasury stock, at cost (14,719,662 shares in 2021 and 14,428,235 shares in 2020)
Accumulated other comprehensive income
Treasury stock, at cost (16,039,648 shares in 2025 and 15,261,136 shares in 2024)
Encompass Health shareholders’ equity
Noncontrolling interests
Total shareholders’ equity

Total liabilities and shareholders' equity

Comments